4//SEC Filing
Dorsch Marion 4
Accession 0001179110-20-007715
CIK 0001597264other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 4:10 PM ET
Size
8.4 KB
Accession
0001179110-20-007715
Insider Transaction Report
Form 4
Dorsch Marion
Chief Scientific Officer
Transactions
- Sale
Common Stock
2020-06-19$79.00/sh−4,600$363,400→ 15,250 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-06-19−4,600→ 61,800 totalExercise: $37.11Exp: 2026-11-21→ Common Stock (4,600 underlying) - Exercise/Conversion
Common Stock
2020-06-19$37.11/sh+4,600$170,706→ 19,850 total
Footnotes (2)
- [F1]Effected pursuant to a trading plan adopted on April 3, 2019 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]This option was granted on November 21, 2016. This option vested with respect to 25% of the shares underlying the option on November 21, 2017 and vests as to an additional 1/48th of the shares underlying the option each month thereafter.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001690460
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 4:10 PM ET
- Size
- 8.4 KB